Startup Seeks to Reconsider Ban on Gene-Edited Babies
Origin Genomics aims to prove the potential benefits of editing disease-causing genes in human embryos outweigh the risks.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
This story has stopped developing; this page is its permanent record. More from that day
The story so far
2 publishers have covered this in 2 articles since 29 Sept 2026. NPR Health published first, on 29 September at 17:00 UTC; Science Latest followed 21h 30m later. The most recent article, from Science Latest, appeared on 30 September at 14:30 UTC.
Outlets reporting it: NPR Health (major outlet), Science Latest (major outlet).
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- Origin Genomics